Health Care · Biological Products, (No Diagnostic Substances) · Nasdaq · CIK 1840229 · FYE Dec 31 · Prices AT CLOSE 2026-08-19 (USD) Last $11.13 · Day −7.25% · Mkt cap $61M · 1Y −24.3% · Off 52W high −34.5% · Vol (1Y) 76.3% Price2023-08-21 → 2026-08-19 INKT close: $16.6 on 2023-08-21 to $11.1 on 2026-08-19. Split-adj closes · 240 of 1,064 · price returnⓘ At a glance | Short interest1.8% of sh out | | Days to cover9.4d | | 13F net flow (QoQ)+0.16% | | Top-10 13F concentration99.8% | | Next report (est.)2026-11-12 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD−0.2% | | 1Y−24.3% | | 3Y−33.0% | | Since incept. (ann.)−44.8% |
Price return · from 2021-11-08ⓘ Risk | Ann. volatility (1Y)76.3% | | Ann. volatility (3Y)436.2% | | Sharpe (1Y)0.00 | | Sharpe (3Y)0.48 | | Max drawdown (1Y)−47.5% | | Max drawdown (3Y)−86.7% | | Beta (3Y vs SPY)1.22 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 59,364 | $625,103 | 1.20% | new | | GEODE CAPITAL MANAGEMENT, LLC | 17,345 | $182,666 | 0.35% | +21.7% | | Longbow Finance SA | 16,667 | $175,504 | 0.34% | +0.0% | | UBS Group AG | 15,202 | $160,077 | 0.31% | +59.2% | | VANGUARD FIDUCIARY TRUST CO | 8,287 | $87,262 | 0.17% | new | | BlackRock, Inc. | 6,203 | $65,317 | 0.12% | +0.0% | | Steward Partners Investment Advisory, LLC | 2,000 | $21,060 | 0.04% | new | | Annis Gardner Whiting Capital Advisors, LLC | 200 | $2,106 | 0.00% | new |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-08-13 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-13 | −$0.62 | — | — | — | | 2026-03-31 | 2026-05-15 | −$0.57 | — | — | — | | 2025-09-30 | 2025-11-14 | −$0.65 | — | — | — | | 2025-06-30 | 2025-08-14 | −$1.06 | — | — | — |
As-reported XBRL · next 2026-11-12 est.ⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
|
